239 related articles for article (PubMed ID: 36087193)
21. Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.
Hille JJ; Webster-Cyriaque J; Palefski JM; Raab-Traub N
Oral Dis; 2002; 8 Suppl 2():161-8. PubMed ID: 12164651
[TBL] [Abstract][Full Text] [Related]
22. The prevention of infection-associated cancers.
De Flora S; Bonanni P
Carcinogenesis; 2011 Jun; 32(6):787-95. PubMed ID: 21436188
[TBL] [Abstract][Full Text] [Related]
23. Cancers attributable to infectious agents in Italy.
Collatuzzo G; La Vecchia C; Parazzini F; Alicandro G; Turati F; Di Maso M; Malvezzi M; Pelucchi C; Negri E; Boffetta P
Eur J Cancer; 2023 Apr; 183():69-78. PubMed ID: 36801622
[TBL] [Abstract][Full Text] [Related]
24. Cancers related to viral agents that have a direct role in carcinogenesis: pathological and diagnostic techniques.
Carbone A; De Paoli P
J Clin Pathol; 2012 Aug; 65(8):680-6. PubMed ID: 22496514
[TBL] [Abstract][Full Text] [Related]
25. Human retroviruses: their role in cancer.
Blattner WA
Proc Assoc Am Physicians; 1999; 111(6):563-72. PubMed ID: 10591085
[TBL] [Abstract][Full Text] [Related]
26. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
Dzobo K
OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476
[TBL] [Abstract][Full Text] [Related]
27. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
28. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
29. Cancers in Australia in 2010 attributable to infectious agents.
Antonsson A; Wilson LF; Kendall BJ; Bain CJ; Whiteman DC; Neale RE
Aust N Z J Public Health; 2015 Oct; 39(5):446-51. PubMed ID: 26437730
[TBL] [Abstract][Full Text] [Related]
30. Viral infections and cancer: epidemiological aspects.
Serraino D; Piselli P; Scognamiglio P
J Biol Regul Homeost Agents; 2001; 15(3):224-8. PubMed ID: 11693428
[TBL] [Abstract][Full Text] [Related]
31. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
32. Tumorigenesis and diagnostic practice applied in two oncogenic viruses: Epstein Barr virus and T-cell lymphotropic virus-1-Mini review.
Manivannan AC; Devaraju V; Velmurugan P; Sathiamoorthi T; Sivakumar S; Subbiah SK; Ravi AV
Biomed Pharmacother; 2021 Oct; 142():111974. PubMed ID: 34343895
[TBL] [Abstract][Full Text] [Related]
33. Pathogens and Carcinogenesis: A Review.
Hatta MNA; Mohamad Hanif EA; Chin SF; Neoh HM
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34203649
[TBL] [Abstract][Full Text] [Related]
34. Infections and cancer: established associations and new hypotheses.
de Martel C; Franceschi S
Crit Rev Oncol Hematol; 2009 Jun; 70(3):183-94. PubMed ID: 18805702
[TBL] [Abstract][Full Text] [Related]
35. Incidence of infection-associated cancers in Italy and prevention strategies.
De Flora S; Crocetti E; Bonanni P; Ferro A; Vitale F;
Epidemiol Prev; 2015; 39(4 Suppl 1):14-20. PubMed ID: 26499410
[TBL] [Abstract][Full Text] [Related]
36. Infection, immunity, and cancer.
Persing DH; Prendergast FG
Arch Pathol Lab Med; 1999 Nov; 123(11):1015-22. PubMed ID: 10539899
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.
Wahman A; Melnick SL; Rhame FS; Potter JD
Epidemiol Rev; 1991; 13():178-99. PubMed ID: 1765111
[TBL] [Abstract][Full Text] [Related]
38. Cancer and viruses.
Chow VT
Ann Acad Med Singap; 1993 Mar; 22(2):163-9. PubMed ID: 8103316
[TBL] [Abstract][Full Text] [Related]
39. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
40. Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
Aligo J; Walker M; Bugelski P; Weinstock D
J Immunotoxicol; 2015; 12(1):1-15. PubMed ID: 24512328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
